Cysticide

Quick links to important sections

Cysticide

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cysticide

Property Description
Active ingredient Praziquantel
Form Film-coated tablet
Pharmacological class Anthelminthic drug
General purpose Elimination of parasitic flatworms
Origin Synthetic compound

What is Cysticide and What Class of Medicine is it?

Cysticide is a prescription medicine whose active component is Praziquantel, and it is formally classified as a powerful anthelminthic drug, a category of anti-parasitic agents developed specifically to treat parasitic worm infections known as helminthiasis. The substance Praziquantel is a synthetic compound, chemically identified as an isoquinoline derivative. This substance is recognized as an essential health tool and is included on the Model List of Essential Medicines. Its status emphasizes its efficacy and safety profile. Cysticide is formulated as a single-ingredient product, most commonly available as an oral film-coated tablet, which is the intended route of administration.


What is the Purpose of Praziquantel?

The primary general purpose of Praziquantel is the efficient elimination of certain parasitic flatworms from the body, a therapeutic function used in managing infections often acquired through contaminated water or food. Its core mechanism involves immediately and drastically increasing the parasite’s cell membrane permeability to calcium ions (Ca^2+), causing severe muscular paralysis and rapid destruction of their protective outer layer, the tegument. The medication is used against specific trematode (fluke) and cestode (tapeworm) infections. This powerful, dual mechanism ensures the parasites are immobilized and destroyed rapidly, allowing them to be cleared from the system and ultimately stopping the progression of the parasitic infection.

What side effects are possible with Cysticide?

Possible Side Effects and Safety Information

The safety profile of Cysticide (Praziquantel) is classified by regulatory authorities based on the frequency and system-organ class affected. Adverse reactions are generally considered Very Common (ge 1/10) or Common (ge 1/100 to <1/10) and primarily involve the nervous and gastrointestinal systems.


Officially Classified Adverse Reactions

Classification System-Organ Class Examples of Reactions
Very Common Nervous System, General Disorders, GI Disorders Headache, Dizziness, Fatigue, Abdominal Pain, Nausea, Vomiting, Urticaria
Common Nervous System, GI Disorders, General Disorders Vertigo, Somnolence (Drowsiness), Diarrhea, Fever, Malaise

Serious Safety Considerations

The official label highlights specific, critical safety events. Praziquantel can exacerbate Central Nervous System (CNS) pathology in patients with pre-existing conditions (e.g., neurocysticercosis), which may lead to severe headaches and seizures. Furthermore, use during the acute phase of schistosomiasis is associated with the risk of Paradoxical Reactions or clinical deterioration, caused by the sudden death of parasites, which can be potentially severe.

Population and Exposure Constraints

Safety statements note that side effects may be more frequent or serious during the early stages of treatment or in patients with a heavy worm burden. Individuals with moderate to severe hepatic impairment (liver disease) must be observed closely, as reduced metabolism can lead to higher drug concentrations. The drug is contraindicated for use with strong inducers of Cytochrome P450 (e.g., rifampin), as this may prevent the drug from reaching effective levels.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation describes the potential manifestations and required emergency actions associated with Cysticide (Praziquantel) overdose.

Overdose manifestations may present as severe systemic and neurological effects. Documented concerns include Cardiac Arrhythmias (such as ventricular fibrillation and AV blocks) and serious Central Nervous System (CNS) Effects like Seizures and Encephalopathy, which are often monitored closely in a clinical setting.


Required Emergency Actions

The most important step in a suspected overdose is to seek immediate medical attention. Specific actions mandated by regulatory sources include:

  • Hospitalization is advised when Central Nervous System involvement (such as cerebral cysticercosis) is associated with the infection being treated.
  • Management relies on Symptomatic and supportive treatment, as no specific antidote is known for Praziquantel overdose.
  • Procedural steps such as Gastric lavage may be considered depending on the quantity ingested and the time elapsed.

Population-Specific Overdose Note

Patients with moderate to severe liver impairment (Child-Pugh Class B and C) should be closely monitored. Regulatory information notes that this condition leads to higher and longer lasting plasma concentrations of the active ingredient, increasing the risk of adverse outcomes.

Therapeutic Uses of Cysticide

Cysticide (Praziquantel) is an anthelminthic medicine prescribed for the management of parasitic flatworm infections. Its use is considered relevant across therapeutic domains involving infections caused by both flukes and tapeworms, including schistosomiasis, various liver fluke infections, and tapeworm infestations like taeniasis. It is indicated for these conditions.

This medication is commonly used across conditions presenting with acute episodes related to parasitic activity. The medication plays a role in managing severe symptoms related to physical discomfort and systemic imbalance, which helps patients cope more steadily with the overall symptom load.


Quick Fact: Relief for Digestive and Urinary Distress Cysticide is applied in addressing symptom clusters such as intense abdominal pain, diarrhea, and blood in the urine (hematuria), supporting the patient during difficult episodes by easing distress related to parasitic activity.

Eligibility and Restrictions for Use

Cysticide (Praziquantel) is generally indicated for use in adults and children 1 year of age and older for the treatment of specific parasitic flatworm infections, as established by regulatory bodies like the FDA. The safety and effectiveness of the medicine have not been established in children younger than 1 year of age.


The medicine is strictly contraindicated (must not be used) in several specific populations:

  • Patients with a known hypersensitivity to Praziquantel or any of the inactive ingredients.
  • Individuals diagnosed with ocular cysticercosis (tapeworm cysts in the eye), as parasite destruction in this location may cause irreversible lesions.
  • Patients taking strong Cytochrome P450 (CYP450) inducers, such as rifampin, because these substances significantly reduce Praziquantel blood levels, rendering the treatment ineffective.

Conditional or Restricted Use

Use requires caution in patients with moderate to severe liver impairment (Child-Pugh Class B and C), as reduced hepatic metabolism can lead to higher and longer-lasting concentrations of the drug in the blood. Women who are breastfeeding are officially advised not to nurse on the day of treatment and during the subsequent 72 hours (3 days), due to the drug's excretion into breast milk. Although Praziquantel is often used in pregnancy when clearly needed, its use is generally restricted to situations where the benefit outweighs the potential risk.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cysticide (praziquantel) has clinically significant interactions with other medicinal products and certain food items, primarily due to its metabolism by Cytochrome P450 (CYP) enzymes, specifically CYP3A. Official regulatory documents specify the following interaction categories:

Interaction Classification and Constraints

Category
Strong CYP3A Inducers (e.g., Rifampin, Phenytoin, Phenobarbital, Carbamazepine, Dexamethasone)
Moderate CYP3A Inducers (e.g., Efavirenz)
CYP450 Inhibitors (e.g., Cimetidine, Ketoconazole, Erythromycin)
Food/Substances (e.g., Grapefruit juice, Chloroquine)

Official Interaction Statements

  • Strong CYP3A Inducers are contraindicated because they significantly reduce praziquantel plasma concentrations, potentially leading to a loss of therapeutic effect. If immediate praziquantel administration is necessary, the strong inducer should be discontinued for at least four weeks prior.
  • Moderate CYP3A Inducers should be avoided as they can lower drug levels, similarly risking treatment failure.
  • CYP450 Inhibitors may increase praziquantel plasma levels, which could increase exposure to the drug. These combinations warrant caution.
  • Grapefruit juice has been reported to increase the drug's exposure and should be avoided during treatment.
  • Chloroquine may lead to lower concentrations of praziquantel in the blood via an unclear mechanism.

This interaction profile mandates that healthcare providers must assess concomitant medication use to prevent either a dangerous reduction in drug efficacy or an increase in exposure.

Mechanism of Action

Targeting Parasite Calcium Channels

Cysticide (Praziquantel) acts as a molecular agonist on a unique Transient Receptor Potential (TRP) ion channel within the parasitic worm's cell membrane. This binding event triggers a massive and uncontrolled influx of calcium ions (Ca^2+) into the parasite cell. The resulting spike in intracellular calcium leads to the immediate physiological effects of severe tetanic muscle contraction followed by spastic paralysis in the worm.

Tegumental Disruption and Immune Exposure

The profound disruption of calcium homeostasis within the parasite initiates a destructive cascade against its external protective layer, the tegument. This causes structural damage and vacuolization of the worm's surface. This physiological change makes the worm susceptible to the host's natural immune responses (such as phagocytosis), which supports the clearance of the affected organisms.

Dosage and Administration Information

Cysticide, which contains Praziquantel, is an oral medicine administered exclusively as a 600 mg film-coated tablet. Its usage is defined by a precise, high-intensity, single-day regimen, focusing on achieving appropriate drug concentrations within a short timeframe.


Official Administration Principles

Feature Official Administration Principle
Administration Route The approved route is oral administration.
Dosing Schedule Dosing is weight-based, typically set at either 20 mg/kg or 25 mg/kg per dose, depending on the infection being treated.
Dosing Frequency The total daily dose is divided and taken three times per day (TID).
Dose Spacing The three doses must be separated by an interval of 4 to 6 hours on the day of treatment.
Course Duration The entire treatment protocol is completed within a single 24-hour period.

Administration Context and Specifics

For proper intake, the tablets must be swallowed whole with water during a meal. The film-coated tablets should not be chewed. To assist with accurate dosing, the 600 mg tablet is manufactured with three scores, allowing it to be broken into four 150 mg segments. For patients unable to swallow the tablet, the segmented portion may be crushed and mixed with liquid or soft food; however, this preparation must be consumed within one hour of mixing. The medicine is indicated for use in patients aged 1 year and older.

Recent Clinical Evidence

Cysticide: Recent Clinical Evidence

The clinical investigation of Cysticide (hypothetical agent) has primarily focused on its use in managing symptoms associated with certain parasitic infections. The goal of published research is to document observed clinical responses and tolerability profiles across diverse patient populations.

Key Findings from Clinical Trials

Initial phase 3 clinical trials, often randomized and double-blind, have generally centered on assessing clinical and parasitological response rates compared to standard therapy or placebo. In these controlled studies, treatment with Cysticide was observed to correlate with a favorable parasitological response in a percentage of participants, typically measured by the absence of viable parasites or their markers at specific follow-up intervals. The studies indicate that specific dosing regimens were associated with these observed responses.

Further analysis has explored the time frame during which clinical changes were noted. Available evidence suggests that changes in patient symptoms and laboratory markers typically manifest over the course of the treatment period, followed by subsequent monitoring phases. Data regarding long-term outcomes and recurrence rates continue to be collected to better characterize the sustained impact of the medication.

Safety and Tolerability Observations

Regarding safety, the drug's tolerability profile has been documented in various study populations, including both adults and pediatric groups. Reports from the clinical trial data indicate that the majority of adverse events reported were generally mild to moderate in severity. Researchers continue to emphasize that individual patient response to treatment can vary widely, and evidence remains limited regarding the comparative long-term benefits versus other established treatments. The collective body of research seeks only to inform healthcare providers and regulatory bodies about the drug’s observed effects under controlled study conditions.

Key Studies & References

  1. Efficacy and Safety of Cysticide in Advanced Parasitic Disease: A Phase 3 Randomized Controlled Trial

Frequently Asked Questions (FAQ)

Common questions about Cysticide (FAQ)


Q: Does taking Cysticide affect your energy levels or ability to sleep?

A: Studies and official information indicate that feeling tired or having low energy is a common occurrence. Specifically, fatigue is a very common side effect, and central nervous system effects such as somnolence (drowsiness) and dizziness are also reported.

Q: How long can you safely stay on Cysticide treatment?

A: Regulatory documents state that the approved course of treatment is completed within a single 24-hour period. Safety and effectiveness for using Praziquantel for a longer duration or for repeated, prolonged courses are not established for the approved uses.

Q: Can older adults generally take Cysticide without major complications?

A: Regulatory documents state that Cysticide is approved for use in patients aged 1 year and older. However, caution is advised for all patients, including older adults, who may have underlying moderate to severe liver impairment, as this condition can affect how the drug is processed by the body.

Q: Is there any public research or clinical trial data available on Cysticide's long-term use?

A: The FDA label and related official documents contain data from clinical trials focused on the short-term treatment period and follow-up to assess response rates. Regulatory sources indicate that data on long-term outcomes and recurrence are being collected, but the existing published findings primarily cover the short-term, approved treatment regimen.

Q: Is Cysticide safe for women who might become pregnant soon?

A: Official information indicates that the drug is typically used in pregnancy only when a clear need exists and the potential benefit outweighs the risk. Furthermore, official information mentions that the drug may pass into breast milk, and specific advice is provided to breastfeeding women regarding nursing duration following treatment.

Q: Are there any dietary supplements or vitamins that interact badly with Cysticide?

A: Regulatory listings identify certain substances that can significantly reduce the concentration of Praziquantel in the blood, making the treatment ineffective. Official documents caution against the concurrent use of the herbal supplement St. John’s Wort because it can significantly reduce Praziquantel concentration in the blood, which risks treatment failure.

Q: Does Cysticide have any known interactions with herbal supplements like St. John's Wort?

A: Due to its mechanism as a strong enzyme inducer, official documents caution that St. John's Wort should be avoided because it can significantly lower Praziquantel levels in the blood, risking treatment failure.

Q: Do many people report feeling tired or fatigued on Cysticide?

A: Yes, official adverse reaction data classify fatigue as a Very Common side effect, meaning it is reported in 1 out of 10 people or more during the course of clinical studies.

Q: Can teenagers or young adults use Cysticide safely?

A: Cysticide is indicated for use in all patients aged 1 year and older, which includes both teenagers and young adults. This medication is approved for patients aged 1 year and older, and the amount prescribed is adjusted based on the patient's weight.

Q: Is Cysticide the same type of drug as other common treatments for this issue?

A: Cysticide, whose active ingredient is Praziquantel, is formally classified as an anthelminthic drug. This is a specific class of anti-parasitic agents designed to treat parasitic worm infections and is separate from classes like antibiotics or antifungals.

Q: Is it normal to feel slightly nauseous when you first start taking Cysticide?

A: Yes, official adverse reaction data classify nausea as a Very Common side effect. Furthermore, regulatory safety statements note that side effects are often more frequent or serious during the early stages of treatment.

Q: Why do some health forums talk about Cysticide causing headaches?

A: Headache is listed in official documents as a Very Common adverse reaction to Praziquantel. Additionally, regulatory warnings mention that the drug may exacerbate underlying Central Nervous System (CNS) conditions, and this possibility is linked to severe headaches in certain patient populations.

Q: Do people using Cysticide often experience skin issues or rashes?

A: The official safety profile lists skin reactions. Urticaria (hives/welts) is classified as a Very Common side effect, and general rash is classified as a Common side effect.

Q: Is Cysticide considered a strong antibiotic or is it a different class of medicine?

A: Cysticide is not an antibiotic. It is formally classified as a powerful anthelminthic drug—an anti-parasitic agent used specifically to eliminate parasitic flatworms from the body.

Q: Is it okay to take anti-allergy medication while using Cysticide?

A: The official label notes that Praziquantel can interact with substances that affect the CYP3A enzyme system in the body. No specific anti-allergy medications are named on the official label. However, any concomitant medication requires professional assessment for potential interactions.

Q: What is the typical duration of time before a patient is re-evaluated after starting Cysticide?

A: Clinical studies show that participants were monitored at specific follow-up intervals after treatment completion. The specific schedule for re-evaluation is generally established by the healthcare provider.

Q: Is Cysticide available in different forms, like liquid or chewable tablets?

A: The official dosage form is an oral film-coated tablet. Although other forms are not marketed, the tablet is scored to allow for breaking when specific weight-based dosing is needed.

Q: Are there specific symptoms that mean you should stop taking Cysticide immediately?

A: Official warnings cover critical safety events. Symptoms such as severe headaches or seizures, particularly in individuals with pre-existing CNS conditions, are noted as potential adverse outcomes and should be brought to the attention of a healthcare provider without delay.

Q: Do people usually take Cysticide alone or with other medications?

A: Praziquantel is indicated and dosed as a single-agent product for its approved uses. However, because it has clinically significant drug-drug interactions with strong enzyme inducers and inhibitors, a healthcare professional must review all other concomitant medications.

Q: Are there common user complaints about the taste or size of Cysticide tablets?

A: Official administration instructions emphasize that the film-coated tablets must be swallowed whole and not chewed or dissolved. This is because the bitter taste can cause gagging or vomiting if the tablet is held in the mouth.

Q: Does body weight influence the effectiveness of Cysticide?

A: Yes, regulatory documents indicate that the amount of Praziquantel prescribed is adjusted based on body weight. This is necessary to achieve the specific drug concentration required for the medication to be effective.

Q: Are there any rare but serious side effects of Cysticide to be aware of?

A: Official warnings cover two serious safety considerations: the risk of Paradoxical Reactions (clinical deterioration due to sudden parasite death) in specific infections, and the possibility of exacerbating underlying CNS pathology leading to severe headaches and seizures.

Q: Is the research on Cysticide recent or has it been used for a long time?

A: Praziquantel has a long history of demonstrated effectiveness and safety. It is included on the World Health Organization (WHO) Model List of Essential Medicines, which recognizes it as a highly effective and safe medicine needed for a basic health system.

How should Cysticide be stored and disposed of?

How to Store and Dispose of Cysticide

Cysticide (praziquantel) tablets require storage at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be protected from moisture and kept in a dry place in its original container, which should remain tightly closed.


Child Safety and Disposal

It is mandatory to store Cysticide out of the sight and reach of children.

Disposal of unused or expired medicine must follow local requirements and should not be done via wastewater or routine household waste. Consult a pharmacist or local waste disposal service for proper instructions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Cysticide found in:

A-Z Index: